A BILL 
To amend the Internal Revenue Code of 1986 to encourage 
investment to renew, restore, and rebuild the American 
economy for our workers, families, and small businesses, 
maximize innovation through research and development, 
and secure America’s medical supplies. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 
3
(a) SHORT TITLE.—This Act may be cited as the 
4
‘‘Commitment to American Growth, Renewal, and Oppor-
5
tunities for Workers, Technology, and Health Act’’ or as 
6
the ‘‘Commitment to American GROWTH Act’’. 
7
23:08 Oct 10, 2020
H11
2 
•HR 11 IH
(b) TABLE OF CONTENTS.—The table of contents of 
1
this Act is as follows: 
2
Sec. 1. Short title; table of contents. 
TITLE I—GROWTH IN BUSINESS INVESTMENT TO BOOST 
AMERICAN WAGES AND JOBS 
Sec. 101. Permanent full expensing for qualified property. 
Sec. 102. Limitation on business interest permanently applied without regard 
to deductions for depreciation, amortization, and depletion. 
TITLE II—GROWTH IN RESEARCH IN AMERICA 
Sec. 201. Repeal amortization of research and experimental expenditures. 
Sec. 202. Doubling the research and experimental tax credit and better access 
to credits for startups. 
Sec. 203. Special rules for transfers of intangible property from controlled for-
eign corporations to United States shareholders. 
TITLE III—GROWTH IN AMERICA’S MEDICAL INDEPENDENCE 
Sec. 301. Domestic medical and drug manufacturing credit. 
Sec. 302. Qualifying advanced medical manufacturing equipment credit. 
Sec. 303. New medical research expenditure component of credit for increasing 
research activities. 
Sec. 304. Refundable portion of research credit for small businesses engaging 
in specified medical research. 
Sec. 305. Exception from passive loss rules for investments in specified medical 
research small business pass-thru entities. 
TITLE IV—GROWTH IN INNOVATION AND TECHNOLOGY 
BREAKTHROUGHS 
Sec. 401. Simplification and expansion of deduction for start-up and organiza-
tional expenditures. 
Sec. 402. Preservation of start-up net operating losses and tax credits after 
ownership change. 
TITLE I—GROWTH IN BUSINESS 
3
INVESTMENT 
TO 
BOOST 
4
AMERICAN WAGES AND JOBS 
5
SEC. 101. PERMANENT FULL EXPENSING FOR QUALIFIED 
6
PROPERTY. 
7
(a) IN GENERAL.—Paragraph (6) of section 168(k) 
8
of the Internal Revenue Code of 1986 is amended to read 
9
as follows: 
10
23:08 Oct 10, 2020
H11
3 
•HR 11 IH
‘‘(6) APPLICABLE PERCENTAGE.—For purposes 
1
of this subsection, the term ‘applicable percentage’ 
2
means, in the case of property placed in service (or, 
3
in the case of a specified plant described in para-
4
graph (5), a plant which is planted or grafted) after 
5
September 27, 2017, 100 percent.’’. 
6
(b) CONFORMING AMENDMENTS.— 
7
(1) Section 168(k) of the Internal Revenue 
8
Code of 1986 is amended— 
9
(A) in paragraph (2)— 
10
(i) in subparagraph (A)— 
11
(I) in clause (i)(V), by inserting 
12
‘‘and’’ at the end; 
13
(II) in clause (ii), by striking 
14
‘‘clause (ii) of subparagraph (E), 
15
and’’ and inserting ‘‘clause (i) of sub-
16
paragraph (E).’’; and 
17
(III) by striking clause (iii); 
18
(ii) in subparagraph (B)— 
19
(I) in clause (i)— 
20
(aa) by striking subclauses 
21
(II) and (III); and 
22
(bb) by redesignating sub-
23
clauses (IV) through (VI) as sub-
24
23:08 Oct 10, 2020
H11
4 
•HR 11 IH
clauses (II) through (IV), respec-
1
tively; 
2
(II) by striking clause (ii); and 
3
(III) by redesignating clauses 
4
(iii) and (iv) as clauses (ii) and (iii), 
5
respectively; 
6
(iii) in subparagraph (C)— 
7
(I) in clause (i), by striking ‘‘and 
8
subclauses (II) and (III) of subpara-
9
graph (B)(i)’’; and 
10
(II) in clause (ii), by striking 
11
‘‘subparagraph (B)(iii)’’ and inserting 
12
‘‘subparagraph (B)(ii)’’; and 
13
(iv) in subparagraph (E)— 
14
(I) by striking clause (i); and 
15
(II) by redesignating clauses (ii) 
16
and (iii) as clauses (i) and (ii), respec-
17
tively; and 
18
(B) in paragraph (5)(A), by striking 
19
‘‘planted before January 1, 2027, or is grafted 
20
before such date to a plant that has already 
21
been planted,’’ and inserting ‘‘planted or graft-
22
ed’’. 
23
(2) Section 460(c)(6)(B) of such Code is 
24
amended by striking ‘‘which’’ and all that follows 
25
23:08 Oct 10, 2020
H11
5 
•HR 11 IH
through the period and inserting ‘‘which has a recov-
1
ery period of 7 years or less.’’. 
2
(c) EFFECTIVE DATE.—The amendments made by 
3
this section shall take effect as if included in section 
4
13201 of Public Law 115–97. 
5
SEC. 102. LIMITATION ON BUSINESS INTEREST PERMA-
6
NENTLY APPLIED WITHOUT REGARD TO DE-
7
DUCTIONS FOR DEPRECIATION, AMORTIZA-
8
TION, AND DEPLETION. 
9
(a) IN GENERAL.—Section 163(j)(8)(A)(v) of the In-
10
ternal Revenue Code of 1986 is amended by striking ‘‘in 
11
the case of taxable years beginning before January 1, 
12
2022’’. 
13
(b) EFFECTIVE DATE.—The amendment made by 
14
this section shall apply to taxable years beginning after 
15
December 31, 2021. 
16
TITLE II—GROWTH IN 
17
RESEARCH IN AMERICA 
18
SEC. 201. REPEAL AMORTIZATION OF RESEARCH AND EX-
19
PERIMENTAL EXPENDITURES. 
20
(a) IN GENERAL.—Section 174 is amended to read 
21
as follows: 
22
‘‘SEC. 174. RESEARCH AND EXPERIMENTAL EXPENDITURES. 
23
‘‘(a) TREATMENT AS EXPENSES.— 
24
23:08 Oct 10, 2020
H11
6 
•HR 11 IH
‘‘(1) IN GENERAL.—A taxpayer may treat re-
1
search or experimental expenditures which are paid 
2
or incurred by him during the taxable year in con-
3
nection with his trade or business as expenses which 
4
are not chargeable to capital account. The expendi-
5
tures so treated shall be allowed as a deduction. 
6
‘‘(2) WHEN METHOD MAY BE ADOPTED.— 
7
‘‘(A) WITHOUT
CONSENT.—A taxpayer 
8
may, without the consent of the Secretary, 
9
adopt the method provided in this subsection 
10
for his first taxable year for which expenditures 
11
described in paragraph (1) are paid or incurred. 
12
‘‘(B) WITH CONSENT.—A taxpayer may, 
13
with the consent of the Secretary, adopt at any 
14
time the method provided in this subsection. 
15
‘‘(3) SCOPE.—The method adopted under this 
16
subsection shall apply to all expenditures described 
17
in paragraph (1). The method adopted shall be ad-
18
hered to in computing taxable income for the taxable 
19
year and for all subsequent taxable years unless, 
20
with the approval of the Secretary, a change to a 
21
different method is authorized with respect to part 
22
or all of such expenditures. 
23
‘‘(b) AMORTIZATION OF CERTAIN RESEARCH AND 
24
EXPERIMENTAL EXPENDITURES.— 
25
23:08 Oct 10, 2020
H11
7 
•HR 11 IH
‘‘(1) IN GENERAL.—At the election of the tax-
1
payer, made in accordance with regulations pre-
2
scribed by the Secretary, research or experimental 
3
expenditures which are— 
4
‘‘(A) paid or incurred by the taxpayer in 
5
connection with his trade or business, 
6
‘‘(B) not treated as expenses under sub-
7
section (a), and 
8
‘‘(C) chargeable to capital account but not 
9
chargeable to property of a character which is 
10
subject to the allowance under section 167 (re-
11
lating to allowance for depreciation, etc.) or sec-
12
tion 611 (relating to allowance for depletion), 
13
may be treated as deferred expenses. In computing 
14
taxable income, such deferred expenses shall be al-
15
lowed as a deduction ratably over such period of not 
16
less than 60 months as may be selected by the tax-
17
payer (beginning with the month in which the tax-
18
payer first realizes benefits from such expenditures). 
19
Such deferred expenses are expenditures properly 
20
chargeable to capital account for purposes of section 
21
1016(a)(1) (relating to adjustments to basis of prop-
22
erty). 
23
‘‘(2) TIME FOR AND SCOPE OF ELECTION.—The 
24
election provided by paragraph (1) may be made for 
25
23:08 Oct 10, 2020
H11
8 
•HR 11 IH
any taxable year, but only if made not later than the 
1
time prescribed by law for filing the return for such 
2
taxable year (including extensions thereof). The 
3
method so elected, and the period selected by the 
4
taxpayer, shall be adhered to in computing taxable 
5
income for the taxable year for which the election is 
6
made and for all subsequent taxable years unless, 
7
with the approval of the Secretary, a change to a 
8
different method (or to a different period) is author-
9
ized with respect to part or all of such expenditures. 
10
The election shall not apply to any expenditure paid 
11
or incurred during any taxable year before the tax-
12
able year for which the taxpayer makes the election. 
13
‘‘(c) LAND AND OTHER PROPERTY.—This section 
14
shall not apply to any expenditure for the acquisition or 
15
improvement of land, or for the acquisition or improve-
16
ment of property to be used in connection with the re-
17
search or experimentation and of a character which is sub-
18
ject to the allowance under section 167 (relating to allow-
19
ance for depreciation, etc.) or section 611 (relating to al-
20
lowance for depletion); but for purposes of this section al-
21
lowances under section 167, and allowances under section 
22
611, shall be considered as expenditures. 
23
‘‘(d) EXPLORATION EXPENDITURES.—This section 
24
shall not apply to any expenditure paid or incurred for 
25
23:08 Oct 10, 2020
H11
9 
•HR 11 IH
the purpose of ascertaining the existence, location, extent, 
1
or quality of any deposit of ore or other mineral (including 
2
oil and gas). 
3
‘‘(e) ONLY REASONABLE RESEARCH EXPENDITURES 
4
ELIGIBLE.—This section shall apply to a research or ex-
5
perimental expenditure only to the extent that the amount 
6
thereof is reasonable under the circumstances.’’. 
7
(b) CLERICAL AMENDMENT.—The table of sections 
8
for part VI of subchapter B of chapter 1 is amended by 
9
striking the item relating to section 174 and inserting the 
10
following new item: 
11
‘‘Sec. 174. Research and experimental expenditures’’. 
(c) CONFORMING AMENDMENTS.— 
12
(1) Section 41(d)(1)(A) is amended by striking 
13
‘‘specified research or experimental expenditures 
14
under section 174’’ and inserting ‘‘expenses under 
15
section 174’’. 
16
(2) Section 280C(c) is amended to read as fol-
17
lows: 
18
‘‘(c) CREDIT FOR INCREASING RESEARCH ACTIVI-
19
TIES.— 
20
‘‘(1) IN GENERAL.—No deduction shall be al-
21
lowed for that portion of the qualified research ex-
22
penses (as defined in section 41(b)) or basic re-
23
search expenses (as defined in section 41(e)(2)) oth-
24
erwise allowable as a deduction for the taxable year 
25
23:08 Oct 10, 2020
H11
10 
•HR 11 IH
which is equal to the amount of the credit deter-
1
mined for such taxable year under section 41(a). 
2
‘‘(2) SIMILAR
RULE
WHERE
TAXPAYER
CAP-
3
ITALIZES RATHER THAN DEDUCTS EXPENSES.—If— 
4
‘‘(A) the amount of the credit determined 
5
for the taxable year under section 41(a)(1), ex-
6
ceeds 
7
‘‘(B) the amount allowable as a deduction 
8
for such taxable year for qualified research ex-
9
penses or basic research expenses (determined 
10
without regard to paragraph (1)), 
11
the amount chargeable to capital account for the 
12
taxable year for such expenses shall be reduced by 
13
the amount of such excess. 
14
‘‘(3) ELECTION OF REDUCED CREDIT.— 
15
‘‘(A) IN
GENERAL.—In the case of any 
16
taxable year for which an election is made 
17
under this paragraph— 
18
‘‘(i) paragraphs (1) and (2) shall not 
19
apply, and 
20
‘‘(ii) the amount of the credit under 
21
section 41(a) shall be the amount deter-
22
mined under subparagraph (B). 
23
‘‘(B) AMOUNT OF REDUCED CREDIT.—The 
24
amount of credit determined under this sub-
25
23:08 Oct 10, 2020
H11
11 
•HR 11 IH
paragraph for any taxable year shall be the 
1
amount equal to the excess of— 
2
‘‘(i) the amount of credit determined 
3
under section 41(a) without regard to this 
4
paragraph, over 
5
‘‘(ii) the product of— 
6
‘‘(I) the amount described in 
7
clause (i), and 
8
‘‘(II) the rate of tax under sec-
9
tion 11(b). 
10
‘‘(C) ELECTION.—An election under this 
11
paragraph for any taxable year shall be made 
12
not later than the time for filing the return of 
13
tax for such year (including extensions), shall 
14
be made on such return, and shall be made in 
15
such manner as the Secretary may prescribe. 
16
Such an election, once made, shall be irrev-
17
ocable. 
18
‘‘(4) CONTROLLED GROUPS.—Paragraph (3) of 
19
subsection (b) shall apply for purposes of this sub-
20
section.’’. 
21
(d) EFFECTIVE DATE.—The amendments made by 
22
this section shall apply to amounts paid or incurred in tax-
23
able years beginning after December 31, 2021. 
24
23:08 Oct 10, 2020
H11
12 
•HR 11 IH
SEC. 202. DOUBLING THE RESEARCH AND EXPERIMENTAL 
1
TAX CREDIT AND BETTER ACCESS TO CRED-
2
ITS FOR STARTUPS. 
3
(a) CREDIT RATE INCREASE.— 
4
(1) IN GENERAL.—Section 41(a) of the Internal 
5
Revenue Code of 1986 is amended by striking ‘‘20 
6
percent’’ and inserting ‘‘40 percent’’. 
7
(2) ALTERNATIVE
SIMPLIFIED
CREDIT.—Sec-
8
tion 41(c)(4)(A) of such Code is amended by strik-
9
ing ‘‘14 percent’’ and inserting ‘‘28 percent’’. 
10
(3) CREDIT RATE IN CASE OF NO RESEARCH 
11
EXPENSES
IN
3
PRECEDING
YEARS.—Section 
12
41(c)(4)(B)(ii) of such Code is amended by striking 
13
‘‘6 percent’’ and inserting ‘‘1⁄2 the credit percentage 
14
in effect under subparagraph (A)’’. 
15
(b) MODIFICATION OF SMALL BUSINESS PORTION 
16
ALLOWED AGAINST PAYROLL TAX.— 
17
(1) INCREASE
IN
LIMITATION.—Paragraphs 
18
(4)(B)(i) and (5)(B)(ii) of section 41(h) of such 
19
Code are each amended by striking ‘‘$250,000’’ and 
20
inserting ‘‘$500,000’’. 
21
(2) QUALIFIED
SMALL
BUSINESS
GROSS
RE-
22
CEIPTS
THRESHOLD.—Section 41(h)(3)(A)(i)(I) of 
23
such Code is amended by striking ‘‘$5,000,000’’ and 
24
inserting ‘‘the dollar amount in effect for the taxable 
25
year under section 448(c)(1)’’. 
26
23:08 Oct 10, 2020
H11
13 
•HR 11 IH
(c) EFFECTIVE DATES.— 
1
(1) SUBSECTION (a).—The amendments made 
2
by subsection (a) shall apply to taxable years begin-
3
ning after December 31, 2020. 
4
(2) SUBSECTION (b).—The amendments made 
5
by subsection (b) shall apply to taxable years begin-
6
ning after December 31, 2019. 
7
SEC. 203. SPECIAL RULES FOR TRANSFERS OF INTANGIBLE 
8
PROPERTY 
FROM 
CONTROLLED 
FOREIGN 
9
CORPORATIONS TO UNITED STATES SHARE-
10
HOLDERS. 
11
(a) IN GENERAL.—Subpart F of part III of sub-
12
chapter N of chapter 1 of the Internal Revenue Code of 
13
1986 is amended by adding at the end the following new 
14
section: 
15
‘‘SEC. 966. TRANSFERS OF INTANGIBLE PROPERTY TO 
16
UNITED STATES SHAREHOLDERS. 
17
‘‘(a) IN GENERAL.—If a controlled foreign corpora-
18
tion holds intangible property on the date of the enact-
19
ment of this section and thereafter distributes such prop-
20
erty to a domestic corporation which is a United States 
21
shareholder with respect to such controlled foreign cor-
22
poration— 
23
‘‘(1) for purposes of part I of subchapter C and 
24
any other provision of this title specified by the Sec-
25
23:08 Oct 10, 2020
H11
14 
•HR 11 IH
retary, the fair market value of such property on the 
1
date of such distribution shall be treated as not ex-
2
ceeding the adjusted basis of such property imme-
3
diately before such distribution, and 
4
‘‘(2) if any portion of such distribution is not 
5
a dividend— 
6
‘‘(A) no gain shall be recognized by such 
7
United States shareholder with respect to such 
8
distribution, and 
9
‘‘(B) the adjusted basis of such property in 
10
the hands of such United States shareholder 
11
immediately after such distribution shall be the 
12
adjusted basis of such property in the hands of 
13
such controlled foreign corporation immediately 
14
before such distribution reduced by the amount 
15
(if any) of gain not recognized by reason of 
16
subparagraph (A) (determined after the appli-
17
cation of paragraph (1)). 
18
‘‘(b) INTANGIBLE PROPERTY.—For purposes of this 
19
section, the term ‘intangible property’ means any— 
20
‘‘(1) patent, copyright, license, invention, for-
21
mula, process, design, pattern, know-how, or format, 
22
‘‘(2) method, program, system, procedure, cam-
23
paign, survey, study, forecast, estimate, or technical 
24
data, 
25
23:08 Oct 10, 2020
H11
15 
•HR 11 IH
‘‘(3) computer software (as defined in section 
1
197(e)(3)(B)), or 
2
‘‘(4) any similar item, which has substantial 
3
value independent of the services of any individual.’’. 
4
(b) CONFORMING AMENDMENTS.— 
5
(1) Section 197(f)(2)(B)(i) of such Code is 
6
amended by inserting ‘‘966(a),’’ after ‘‘731,’’. 
7
(2) The table of sections for subpart F of part 
8
III of subchapter N of chapter 1 of such Code is 
9
amended by adding at the end the following new 
10
item: 
11
‘‘Sec. 966. Transfers of intangible property to United States shareholders.’’. 
(c) EFFECTIVE DATE.—The amendments made by 
12
this section shall apply to distributions made in taxable 
13
years of foreign corporations beginning after December 
14
31, 2020, and to taxable years of United States share-
15
holders in which or with which such taxable years of for-
16
eign corporations end. 
17
TITLE III—GROWTH IN AMER-
18
ICA’S 
MEDICAL 
INDEPEND-
19
ENCE 
20
SEC. 301. DOMESTIC MEDICAL AND DRUG MANUFAC-
21
TURING CREDIT. 
22
(a) IN GENERAL.—Subpart D of part IV of sub-
23
chapter A of chapter 1 of the Internal Revenue Code of 
24
23:08 Oct 10, 2020
H11
16 
•HR 11 IH
1986 is amended by adding at the end the following new 
1
section: 
2
‘‘SEC. 45U. DOMESTIC MEDICAL AND DRUG MANUFAC-
3
TURING CREDIT. 
4
‘‘(a) IN GENERAL.—For purposes of section 38, the 
5
domestic medical and drug manufacturing credit deter-
6
mined under this section for any taxable year is an amount 
7
equal to 10.5 percent of the lesser of— 
8
‘‘(1) the qualified medical and drug manufac-
9
turing income of the taxpayer for the taxable year, 
10
or 
11
‘‘(2) taxable income of the taxpayer for the tax-
12
able year. 
13
‘‘(b) CREDIT LIMITED TO WAGES PAID.— 
14
‘‘(1) IN GENERAL.—The amount of the credit 
15
allowable under subsection (a) for any taxable year 
16
shall not exceed 50 percent of the W–2 wages of the 
17
taxpayer for the taxable year. 
18
‘‘(2) W–2 WAGES.—For purposes of this sec-
19
tion— 
20
‘‘(A) 
IN
GENERAL.—The 
term 
‘W–2 
21
wages’ means, with respect to any person for 
22
any taxable year of such person, the sum of the 
23
amounts described in paragraphs (3) and (8) of 
24
section 6051(a) paid by such person with re-
25
23:08 Oct 10, 2020
H11
17 
•HR 11 IH
spect to employment of employees by such per-
1
son during the calendar year ending during 
2
such taxable year. 
3
‘‘(B) LIMITATION
TO
WAGES
ATTRIB-
4
UTABLE
TO
DOMESTIC
PRODUCTION.—Such 
5
term shall not include any amount which is not 
6
properly allocable to domestic medical and drug 
7
manufacturing gross receipts for purposes of 
8
subsection (c)(1). 
9
‘‘(C) RETURN REQUIREMENT.—Such term 
10
shall not include any amount which is not prop-
11
erly included in a return filed with the Social 
12
Security Administration on or before the 60th 
13
day after the due date (including extensions) 
14
for such return. 
15
‘‘(3) ACQUISITIONS, DISPOSITIONS, AND SHORT 
16
TAXABLE YEARS.—The Secretary shall provide for 
17
the application of this subsection in cases of a short 
18
taxable year or where the taxpayer acquires, or dis-
19
poses of, the major portion of a trade or business or 
20
the major portion of a separate unit of a trade or 
21
business during the taxable year. 
22
‘‘(c) QUALIFIED MEDICAL
AND DRUG MANUFAC-
23
TURING INCOME.—For purposes of this section— 
24
23:08 Oct 10, 2020
H11
18 
•HR 11 IH
‘‘(1) IN GENERAL.—The term ‘qualified medical 
1
and drug manufacturing income’ for any taxable 
2
year means an amount equal to the excess (if any) 
3
of— 
4
‘‘(A) the taxpayer’s domestic medical and 
5
drug manufacturing gross receipts for the tax-
6
able year, over 
7
‘‘(B) the sum of— 
8
‘‘(i) the cost of goods sold that are al-
9
locable to such receipts, and 
10
‘‘(ii) other expenses, losses, or deduc-
11
tions which are properly allocable to such 
12
receipts. 
13
‘‘(2) ALLOCATION
METHOD.—The Secretary 
14
shall prescribe rules for the proper allocation of 
15
items described in paragraph (1)(B) for purposes of 
16
determining qualified medical and drug manufac-
17
turing income. Such rules shall provide for the prop-
18
er allocation of items whether or not such items are 
19
directly allocable to domestic medical and drug man-
20
ufacturing gross receipts. 
21
‘‘(3) 
SPECIAL
RULES
FOR
DETERMINING 
22
COSTS.— 
23
‘‘(A) IN GENERAL.—For purposes of deter-
24
mining costs under clause (i) of paragraph 
25
23:08 Oct 10, 2020
H11
19 
•HR 11 IH
(1)(B), any item or service brought into the 
1
United States shall be treated as acquired by 
2
purchase, and its cost shall be treated as not 
3
less than its value immediately after it entered 
4
the United States. 
5
‘‘(B) EXPORTS FOR FURTHER MANUFAC-
6
TURE.—In the case of any property described 
7
in subparagraph (A) that had been exported by 
8
the taxpayer for further manufacture, the in-
9
crease in cost or adjusted basis under subpara-
10
graph (A) shall not exceed the difference be-
11
tween the value of the property when exported 
12
and the value of the property when brought 
13
back into the United States after the further 
14
manufacture. 
15
‘‘(4) DOMESTIC MEDICAL AND DRUG MANUFAC-
16
TURING GROSS RECEIPTS.— 
17
‘‘(A) IN
GENERAL.—The term ‘domestic 
18
medical and drug manufacturing gross receipts’ 
19
means the gross receipts of the taxpayer which 
20
are derived from any sale, exchange, or other 
21
disposition of— 
22
‘‘(i) any active pharmaceutical ingre-
23
dient, or 
24
‘‘(ii) any qualified countermeasure, 
25
23:08 Oct 10, 2020
H11
20 
•HR 11 IH
which was manufactured or produced by the 
1
taxpayer in whole or in significant part within 
2
the United States. 
3
‘‘(B) ACTIVE
PHARMACEUTICAL
INGRE-
4
DIENT.—The term ‘active pharmaceutical ingre-
5
dient’ means any substance or mixture of sub-
6
stances intended to be used in the manufacture 
7
of a drug product and (when so used) becomes 
8
an active ingredient in the drug product. 
9
‘‘(C) QUALIFIED COUNTERMEASURE.—The 
10
term ‘qualified countermeasure’ has the mean-
11
ing given such term in section 319F–1(a)(2) of 
12
the Public Health Service Act (42 U.S.C. 
13
247d–6a(a)(2)).’’ 
14
‘‘(D) PARTNERSHIPS
OWNED
BY
EX-
15
PANDED
AFFILIATED
GROUPS.—For purposes 
16
of this paragraph, if all of the interests in the 
17
capital and profits of a partnership are owned 
18
by members of a single expanded affiliated 
19
group at all times during the taxable year of 
20
such partnership, the partnership and all mem-
21
bers of such group shall be treated as a single 
22
taxpayer during such period. 
23
‘‘(d) DEFINITIONS AND SPECIAL RULES.—For pur-
24
poses of this section— 
25
23:08 Oct 10, 2020
H11
21 
•HR 11 IH
‘‘(1) APPLICATION OF SECTION TO PASS-THRU 
1
ENTITIES.— 
2
‘‘(A) PARTNERSHIPS
AND
S
CORPORA-
3
TIONS.—In the case of a partnership or S cor-
4
poration— 
5
‘‘(i) this section shall be applied at the 
6
partner or shareholder level, 
7
‘‘(ii) each partner or shareholder shall 
8
take into account such person’s allocable 
9
share of each item described in subpara-
10
graph (A) or (B) of subsection (c)(1) (de-
11
termined without regard to whether the 
12
items described in such subparagraph (A) 
13
exceed the items described in such sub-
14
paragraph (B)), and 
15
‘‘(iii) each partner or shareholder 
16
shall be treated for purposes of subsection 
17
(b) as having W–2 wages for the taxable 
18
year in an amount equal to such person’s 
19
allocable share of the W–2 wages of the 
20
partnership or S corporation for the tax-
21
able year (as determined under regulations 
22
prescribed by the Secretary). 
23
‘‘(B) TRUSTS AND ESTATES.—In the case 
24
of a trust or estate— 
25
23:08 Oct 10, 2020
H11
22 
•HR 11 IH
‘‘(i) the items referred to in subpara-
1
graph (A)(ii) (as determined therein) and 
2
the W–2 wages of the trust or estate for 
3
the taxable year, shall be apportioned be-
4
tween the beneficiaries and the fiduciary 
5
(and among the beneficiaries) under regu-
6
lations prescribed by the Secretary, and 
7
‘‘(ii) for purposes of paragraph (2), 
8
adjusted gross income of the trust or es-
9
tate shall be determined as provided in sec-
10
tion 67(e) with the adjustments described 
11
in such paragraph. 
12
‘‘(C) REGULATIONS.—The Secretary may 
13
prescribe rules requiring or restricting the allo-
14
cation of items and wages under this paragraph 
15
and may prescribe such reporting requirements 
16
as the Secretary determines appropriate. 
17
‘‘(2) APPLICATION
TO
INDIVIDUALS.—In the 
18
case of an individual, subsection (a)(2) shall be ap-
19
plied by substituting ‘adjusted gross income’ for 
20
‘taxable income’. For purposes of the preceding sen-
21
tence, adjusted gross income shall be determined 
22
after application of sections 86, 135, 137, 219, 221, 
23
222, and 469. 
24
23:08 Oct 10, 2020
H11
23 
•HR 11 IH
‘‘(3) 
SPECIAL
RULE
FOR
AFFILIATED 
1
GROUPS.— 
2
‘‘(A) IN GENERAL.—All members of an ex-
3
panded affiliated group shall be treated as a 
4
single corporation for purposes of this section. 
5
‘‘(B) EXPANDED
AFFILIATED
GROUP.— 
6
For purposes of this section, the term ‘ex-
7
panded affiliated group’ means an affiliated 
8
group as defined in section 1504(a), deter-
9
mined— 
10
‘‘(i) by substituting ‘more than 50 
11
percent’ for ‘at least 80 percent’ each place 
12
it appears, and 
13
‘‘(ii) without regard to paragraphs (2) 
14
and (4) of section 1504(b). 
15
‘‘(C) ALLOCATION OF CREDIT.—Except as 
16
provided in regulations, the credit under sub-
17
section (a) shall be allocated among the mem-
18
bers of the expanded affiliated group in propor-
19
tion to each member’s respective amount (if 
20
any) of qualified medical and drug manufac-
21
turing income. 
22
‘‘(4) TRADE
OR
BUSINESS
REQUIREMENT.— 
23
This section shall be applied by only taking into ac-
24
23:08 Oct 10, 2020
H11
24 
•HR 11 IH
count items which are attributable to the actual con-
1
duct of a trade or business. 
2
‘‘(5) COORDINATION WITH MINIMUM TAX.—For 
3
purposes of determining alternative minimum tax-
4
able income under section 55, qualified medical and 
5
drug manufacturing income shall be determined 
6
without regard to any adjustments under sections 56 
7
through 59. 
8
‘‘(6) UNRELATED
BUSINESS
TAXABLE
IN-
9
COME.—For purposes of determining the tax im-
10
posed by section 511, subsection (a)(1)(B) shall be 
11
applied by substituting ‘unrelated business taxable 
12
income’ for ‘taxable income’. 
13
‘‘(7) REGULATIONS.—The Secretary shall pre-
14
scribe such regulations as are necessary to carry out 
15
the purposes of this section, including regulations 
16
which prevent more than 1 taxpayer from being al-
17
lowed a credit under this section with respect to any 
18
activity described in subsection (c)(4)(A).’’. 
19
(b) TREATMENT UNDER BASE EROSION TAX.—Sec-
20
tion 59A(b)(1)(B)(ii) of such Code is amended by striking 
21
‘‘plus’’ at the end of subclause (I), by redesignating sub-
22
clause (II) as subclause (III), and by inserting after sub-
23
clause (I) the following new subclause: 
24
23:08 Oct 10, 2020
H11
25 
•HR 11 IH
‘‘(II) the credit allowed under 
1
section 38 for the taxable year which 
2
is properly allocable to the domestic 
3
medical and drug manufacturing cred-
4
it determined under section 45U(a), 
5
plus’’. 
6
(c) PART OF GENERAL BUSINESS CREDIT.—Section 
7
38(b) of such Code is amended by striking ‘‘plus’’ at the 
8
end of paragraph (32), by striking the period at the end 
9
of paragraph (33) and inserting ‘‘, plus’’, and by adding 
10
at the end the following new paragraph: 
11
‘‘(34) the domestic medical and drug manufac-
12
turing credit determined under section 45U(a).’’. 
13
(d) CREDIT ALLOWED AGAINST ALTERNATIVE MIN-
14
IMUM TAX.—Section 38(c)(4)(B) of such Code is amended 
15
by redesignating clauses (x) through (xii) as clauses (xi) 
16
through (xiii), respectively, and by inserting after clause 
17
(ix) the following new clause: 
18
‘‘(x) the credit determined under sec-
19
tion 45U,’’. 
20
(e) CLERICAL AMENDMENT.—The table of sections 
21
for subpart D of part IV of subchapter A of chapter 1 
22
of such Code is amended by adding at the end the fol-
23
lowing new item: 
24
‘‘Sec. 45U. Domestic medical and drug manufacturing credit.’’. 
23:08 Oct 10, 2020
H11
26 
•HR 11 IH
(f) EFFECTIVE DATE.—The amendments made by 
1
this section shall apply to taxable years beginning after 
2
December 31, 2020. 
3
SEC. 302. QUALIFYING ADVANCED MEDICAL MANUFAC-
4
TURING EQUIPMENT CREDIT. 
5
(a) IN GENERAL.—Subpart E of part IV of sub-
6
chapter A of chapter 1 of the Internal Revenue Code of 
7
1986 is amended by adding at the end the following new 
8
section: 
9
‘‘SEC. 48D. QUALIFYING ADVANCED MEDICAL MANUFAC-
10
TURING EQUIPMENT CREDIT. 
11
‘‘(a) IN GENERAL.—For purposes of section 46, the 
12
qualifying advanced medical manufacturing equipment 
13
credit determined under this section for any taxable year 
14
is the applicable percentage of the basis of any qualifying 
15
advanced medical manufacturing equipment placed in 
16
service during such taxable year. 
17
‘‘(b) APPLICABLE PERCENTAGE.—For purposes of 
18
subsection (a), the applicable percentage is— 
19
‘‘(1) 30 percent in the case of equipment which 
20
is placed in service before January 1, 2028, 
21
‘‘(2) 20 percent in the case of equipment which 
22
is placed in service during calendar year 2028, 
23
‘‘(3) 10 percent in the case of equipment which 
24
is placed in service during calendar year 2029, and 
25
23:08 Oct 10, 2020
H11
27 
•HR 11 IH
‘‘(4) 0 percent in the case of equipment which 
1
is placed in service after December 31, 2029. 
2
‘‘(c) QUALIFYING ADVANCED MEDICAL MANUFAC-
3
TURING EQUIPMENT.—For purposes of this section, the 
4
term ‘qualifying advanced medical manufacturing equip-
5
ment’ means property of a character subject to the allow-
6
ance for depreciation— 
7
‘‘(1) which is machinery or equipment that is 
8
designed and used to manufacture a— 
9
‘‘(A) drug (as such term is defined in sec-
10
tion 201(g)(1) of the Federal Food, Drug, and 
11
Cosmetic Act), 
12
‘‘(B) device (as such term is defined in sec-
13
tion 201(h) of such Act), or 
14
‘‘(C) biological product (as such term is 
15
defined in section 351(i) of the Public Health 
16
Service Act), 
17
‘‘(2) which has been identified by the Secretary 
18
(after consultation with the Secretary of Health and 
19
Human Services) as machinery or equipment that— 
20
‘‘(A) incorporates novel technology or uses 
21
an established technique or technology in a new 
22
or innovative way, or 
23
23:08 Oct 10, 2020
H11
28 
•HR 11 IH
‘‘(B) that can improve medical product 
1
quality, address shortages of medicines, and 
2
speed time-to-market, 
3
‘‘(3) which is placed in service in the United 
4
States by the taxpayer, and 
5
‘‘(4) with respect to which depreciation is allow-
6
able. 
7
‘‘(d) CERTAIN
QUALIFIED
PROGRESS
EXPENDI-
8
TURES RULES MADE APPLICABLE.—Rules similar to the 
9
rules of subsections (c)(4) and (d) of section 46 (as in 
10
effect on the day before the enactment of the Revenue 
11
Reconciliation Act of 1990) shall apply for purposes of 
12
this section. 
13
‘‘(e) REGULATIONS.—The Secretary shall prescribe 
14
such regulations or other guidance as may be necessary 
15
to carry out the purposes of this section, including regula-
16
tions which prevent abuse or fraud.’’. 
17
(b) TREATMENT UNDER BASE EROSION TAX.—Sec-
18
tion 59A(b)(1)(B)(ii) of such Code, as amended by section 
19
7 of this Act, is further amended by striking ‘‘plus’’ at 
20
the end of subclause (II), by redesignating subclause (III) 
21
as subclause (IV), and by inserting after subclause (II) 
22
the following new subclause: 
23
‘‘(III) the credit allowed under 
24
section 46 for the taxable year which 
25
23:08 Oct 10, 2020
H11
29 
•HR 11 IH
is properly allocable to the qualifying 
1
advanced 
medical 
manufacturing 
2
equipment credit determined under 
3
section 48D(a), plus’’. 
4
(c) PART OF INVESTMENT CREDIT.—Section 46 of 
5
such Code is amended by striking ‘‘and’’ at the end of 
6
paragraph (5), by striking the period at the end of para-
7
graph (6) and inserting ‘‘, and’’, and by adding at the 
8
end the following new paragraph: 
9
‘‘(7) the qualifying advanced medical manufac-
10
turing equipment credit.’’. 
11
(d) CLERICAL AMENDMENT.—The table of sections 
12
for subpart D of part IV of subchapter A of chapter 1 
13
of such Code is amended by adding at the end the fol-
14
lowing new item: 
15
‘‘Sec. 48D. Qualifying advanced medical manufacturing equipment credit.’’. 
(e) EFFECTIVE DATE.—The amendments made by 
16
this section shall apply to periods after the date of the 
17
enactment of this section under rules similar to the rules 
18
of section 48(m) of the Internal Revenue Code of 1986 
19
(as in effect on the date of the enactment fo the Revenue 
20
Reconciliation Act of 1990). 
21
23:08 Oct 10, 2020
H11
30 
•HR 11 IH
SEC. 303. NEW MEDICAL RESEARCH EXPENDITURE COMPO-
1
NENT 
OF 
CREDIT 
FOR 
INCREASING 
RE-
2
SEARCH ACTIVITIES. 
3
(a) IN GENERAL.—Section 41(a) of the Internal Rev-
4
enue Code of 1986 is amended by striking ‘‘and’’ at the 
5
end of paragraph (2), by striking the period at the end 
6
of paragraph (3) and inserting ‘‘, and’’, and by adding 
7
at the end the following new paragraph: 
8
‘‘(4) 14 percent of specified medical research 
9
expenditures.’’. 
10
(b) SPECIFIED
MEDICAL
RESEARCH
EXPENDI-
11
TURES.—Section 41(f) of such Code is amended by adding 
12
at the end the following new paragraph: 
13
‘‘(7) SPECIFIED MEDICAL RESEARCH EXPENDI-
14
TURES.— 
15
‘‘(A) IN
GENERAL.—The term ‘specified 
16
medical research expenditures’ means amounts 
17
paid or incurred for qualified research with re-
18
spect to any qualified countermeasure. 
19
‘‘(B) QUALIFIED COUNTERMEASURE.—The 
20
term ‘qualified countermeasure’ has the mean-
21
ing given to such term in section 319F–1(a)(2) 
22
of the Public Health Service Act (42 U.S.C. 
23
247d–6a(a)(2)).’’. 
24
(c) DENIAL OF DOUBLE BENEFIT.— 
25
23:08 Oct 10, 2020
H11
31 
•HR 11 IH
(1) TAXABLE YEARS BEGINNING BEFORE JANU-
1
ARY 1, 2021.—In the case of specified medical re-
2
search expenditures (as defined in section 41(f)(7) 
3
of such Code (as added by this section)) paid or in-
4
curred in taxable years beginning before January 1, 
5
2021— 
6
(A) such expenditures shall be treated in 
7
the same manner as qualified research expenses 
8
and basic research expenses under section 
9
280C(c)(1) of such Code (as in effect on the 
10
day before the enactment of the Tax Cuts and 
11
Jobs Act), and 
12
(B) the amount determined under section 
13
280C(c)(2)(A) (as in effect on such day) for the 
14
taxable year shall be increased by the amount 
15
of credit determined for the taxable year under 
16
section 41(a)(4) (as added by this section). 
17
(2) TAXABLE YEARS BEGINNING AFTER DECEM-
18
BER 31, 2020.—Section 280C(c)(1) of such Code is 
19
amended by striking ‘‘section 41(a)(1)’’ and insert-
20
ing ‘‘paragraphs (1) and (4) of section 41(a)’’. 
21
(d) CONFORMING AMENDMENT.—Section 41(f)(1) of 
22
such Code is amended by striking ‘‘and amounts paid or 
23
incurred to energy research consortiums’’ each place it ap-
24
pears and inserting ‘‘, amounts paid or incurred to energy 
25
23:08 Oct 10, 2020
H11
32 
•HR 11 IH
research consortiums, and specified medical research ex-
1
penditures’’. 
2
(e) EFFECTIVE DATE.—The amendments made by 
3
this section shall apply to amounts paid or incurred after 
4
the date of the enactment of this Act, in taxable years 
5
ending after such date. 
6
SEC. 304. REFUNDABLE PORTION OF RESEARCH CREDIT 
7
FOR SMALL BUSINESSES ENGAGING IN SPEC-
8
IFIED MEDICAL RESEARCH. 
9
(a) IN GENERAL.—Section 41 of the Internal Rev-
10
enue Code of 1986 is amended by adding at the end the 
11
following new subsection: 
12
‘‘(i) REFUNDABLE
FOR
SMALL
BUSI-
13
NESSES ENGAGING IN SPECIFIED MEDICAL RESEARCH.— 
14
‘‘(1) IN GENERAL.—At the election of a medical 
15
research small business, the portion of the credit de-
16
termined under this section for the taxable year 
17
which is properly allocable to specified medical re-
18
search shall be treated (other than for purposes of 
19
section 280C) as a credit allowed under subpart C 
20
(and not this subpart). 
21
‘‘(2) MEDICAL RESEARCH SMALL BUSINESS.— 
22
For purposes of this subsection, the term ‘medical 
23
research small business’ means any domestic C cor-
24
poration— 
25
23:08 Oct 10, 2020
H11
33 
•HR 11 IH
‘‘(A) which conducts any specified medical 
1
research during the taxable year, and 
2
‘‘(B) the gross receipts of which (deter-
3
mined under the rules of subsection (c)) for the 
4
taxable year do not exceed $1,000,000. 
5
‘‘(3) SPECIFIED
MEDICAL
RESEARCH.—For 
6
purposes of this subsection, the term ‘specified med-
7
ical research’ means any qualified research with re-
8
spect to qualified countermeasures (as defined in 
9
section 319F–1(a)(2) of the Public Health Service 
10
Act (42 U.S.C. 247d–6a(a)(2))). 
11
‘‘(4) ELECTION.—Any election under this sub-
12
section for any taxable year— 
13
‘‘(A) shall specify the amount of the credit 
14
to which such election applies, 
15
‘‘(B) shall be made on or before the due 
16
date (including extensions) of the return of tax 
17
for the taxable year, 
18
‘‘(C) may not be made for any taxable year 
19
with respect to any portion of the credit deter-
20
mined under this section with respect to which 
21
an election is made under subsection (h), and 
22
‘‘(D) may be revoked only with the consent 
23
of the Secretary. 
24
23:08 Oct 10, 2020
H11
34 
•HR 11 IH
‘‘(5) REGULATIONS.—The Secretary shall pre-
1
scribe such regulations for purposes of this sub-
2
section as may be necessary or appropriate for de-
3
termining proper allocation to specified medical re-
4
search of the portion of any credit allowed to a tax-
5
payer for a taxable year under this section.’’. 
6
(b) CONFORMING AMENDMENT.—Section 1324(b) of 
7
title 31, United States Code, is amended by inserting 
8
‘‘41(i),’’ after ‘‘6428,’’. 
9
(c) EFFECTIVE DATE.—The amendments made by 
10
this section shall apply to taxable years beginning after 
11
December 31, 2020. 
12
SEC. 305. EXCEPTION FROM PASSIVE LOSS RULES FOR IN-
13
VESTMENTS 
IN 
SPECIFIED 
MEDICAL 
RE-
14
SEARCH SMALL BUSINESS PASS-THRU ENTI-
15
TIES. 
16
(a) IN GENERAL.—Subsection (c) of section 469 of 
17
the Internal Revenue Code of 1986 is amended by redesig-
18
nating paragraphs (4) through (7) as paragraphs (5) 
19
through (8), respectively, and by inserting after paragraph 
20
(3) the following new paragraph: 
21
‘‘(4) SPECIFIED
MEDICAL
RESEARCH
ACTIVI-
22
TIES.— 
23
‘‘(A) IN GENERAL.—The term ‘passive ac-
24
tivity’ shall not include any qualified medical re-
25
23:08 Oct 10, 2020
H11
35 
•HR 11 IH
search activity of the taxpayer carried on by a 
1
specified medical research small business pass- 
2
thru entity. 
3
‘‘(B) TREATMENT OF LOSSES AND DEDUC-
4
TIONS.— 
5
‘‘(i) IN GENERAL.—Losses or deduc-
6
tions of a taxpayer in connection with 
7
qualified medical research activities carried 
8
on by a specified medical research small 
9
business pass-thru entity shall not be 
10
treated as losses or deductions, respec-
11
tively, from a passive activity except as 
12
provided in clause (ii) and subparagraph 
13
(C). 
14
‘‘(ii) LIMITATION.—Clause (i) shall 
15
apply to losses and deductions of a tax-
16
payer in connection with a specified med-
17
ical small business pass-thru entity for a 
18
taxable year only to the extent that the ag-
19
gregate losses and deductions of the tax-
20
payer in connection with qualified medical 
21
research activities of such entity for such 
22
taxable year do not exceed the portion of 
23
the taxpayer’s adjusted basis in the tax-
24
payer’s ownership interest in such entity 
25
23:08 Oct 10, 2020
H11
36 
•HR 11 IH
that is attributable to money or other 
1
property contributed— 
2
‘‘(I) in exchange for such owner-
3
ship interest, and 
4
‘‘(II) specifically for use in con-
5
nection with qualified medical re-
6
search activities. 
7
For purposes of the preceding sentence, 
8
the taxpayer’s basis shall not include any 
9
portion of such basis which is attributable 
10
to an increase in a partner’s share of the 
11
liabilities of a partnership that is consid-
12
ered under section 752(a) as a contribution 
13
of money. 
14
‘‘(C) TREATMENT OF CARRYOVERS.—Sub-
15
paragraph (B)(i) shall not apply to the portion 
16
of any loss or deduction that is carried over 
17
under subsection (b) into a taxable year other 
18
than the taxable year in which such loss or de-
19
duction arose. 
20
‘‘(D) QUALIFIED MEDICAL RESEARCH AC-
21
TIVITY.—For purposes of this paragraph, the 
22
term ‘qualified medical research activity’ means 
23
any qualified research (within the meaning of 
24
section 41(d)) with respect to qualified counter-
25
23:08 Oct 10, 2020
H11
37 
•HR 11 IH
measures (as defined in section 319F–1(a)(2) 
1
of the Public Health Service Act (42 U.S.C. 
2
247d–6a(a)(2))). 
3
‘‘(E) 
SPECIFIED
MEDICAL
RESEARCH 
4
SMALL
BUSINESS
PASS-THRU
ENTITY.—For 
5
purposes of this paragraph, the term ‘specified 
6
medical research small business pass-thru enti-
7
ty’ means any domestic pass-thru entity for any 
8
taxable year if— 
9
‘‘(i) more than 80 percent of such en-
10
tity’s expenditures on qualified research for 
11
such taxable year are paid or incurred in 
12
connection with qualified medical research 
13
activities, and 
14
‘‘(ii) the gross receipts (as determined 
15
under the rules of section 41(h)(3)) of 
16
such entity for the taxable year (and each 
17
preceding taxable year) is less than 
18
$1,000,000. 
19
‘‘(F) CAPITAL EXPENDITURES TAKEN INTO 
20
ACCOUNT FOR EXPENDITURES TEST.—An ex-
21
penditure shall not fail to be taken into account 
22
under subparagraph (E)(i) merely because such 
23
expenditure is chargeable to capital account. 
24
23:08 Oct 10, 2020
H11
38 
•HR 11 IH
‘‘(G) PASS-THRU
ENTITY.—For purposes 
1
of this paragraph, the term ‘pass-thru entity’ 
2
means any partnership, S corporation, or other 
3
entity identified by the Secretary as a pass-thru 
4
entity for purposes of this paragraph. 
5
‘‘(H) AGGREGATION RULES.— 
6
‘‘(i) IN GENERAL.—All persons treat-
7
ed as a single employer under subsection 
8
(a) or (b) of section 52, or subsection (m) 
9
or (o) of section 414, shall be treated as a 
10
single entity for purposes of subparagraphs 
11
(E) and (F)(iii). 
12
‘‘(ii) 
LIMITATION
WHERE
ENTITY 
13
WOULD NOT QUALIFY.—No entity shall be 
14
treated as a specified medical research 
15
small business pass-thru entity unless such 
16
entity qualifies as such both with and with-
17
out the application of clause (i).’’. 
18
(b) MATERIAL PARTICIPATION NOT REQUIRED.— 
19
Paragraph (5) of section 469(c) of the Internal Revenue 
20
Code of 1986, as redesignated by subsection (a), is amend-
21
ed by striking ‘‘and (3)’’ in the heading and text and in-
22
serting ‘‘, (3), and (4)’’. 
23
(c) CERTAIN RESEARCH-RELATED DEDUCTIONS AND 
24
CREDITS
OF SPECIFIED MEDICAL RESEARCH SMALL 
25
23:08 Oct 10, 2020
H11
39 
•HR 11 IH
BUSINESS PASS-THRU ENTITIES ALLOWED
FOR PUR-
1
2
(1) DEDUCTION FOR RESEARCH AND EXPERI-
3
MENTAL EXPENDITURES.—Paragraph (2) of section 
4
56(b) of the Internal Revenue Code of 1986 is 
5
amended by adding at the end the following new 
6
subparagraph: 
7
‘‘(E) EXCEPTION FOR SPECIFIED MEDICAL 
8
RESEARCH SMALL BUSINESS PASS-THRU ENTI-
9
TIES.—In the case of a specified medical re-
10
search small business pass-thru entity (as de-
11
fined in section 469(c)(4)), this paragraph shall 
12
not apply to any amount allowable as a deduc-
13
tion under section 174(a).’’. 
14
(2) ALLOWANCE
OF
CERTAIN
RESEARCH-RE-
15
LATED
CREDITS.—Subparagraph (B) of section 
16
38(c)(4) of such Code is amended by redesignating 
17
clauses (ii) through (ix) as clauses (iii) through (x), 
18
respectively, and by inserting after clause (i) the fol-
19
lowing new clause: 
20
‘‘(ii) the credit of an individual tax-
21
payer determined under section 41 to the 
22
extent attributable to a specified medical 
23
research small business pass-thru entity 
24
(as defined in section 469(c)(4)),’’. 
25
23:08 Oct 10, 2020
H11
40 
•HR 11 IH
(d) EXCEPTION TO LIMITATION ON PASS-THRU OF 
1
RESEARCH CREDIT.—Subsection (g) of section 41 of such 
2
Code is amended by adding at the end the following: 
3
‘‘Paragraphs (2) and (4) shall not apply with respect to 
4
any specified medical research small business pass-thru 
5
entity (as defined in section 469(c)(4)).’’. 
6
(e) EFFECTIVE DATE.—The amendments made by 
7
this section shall apply to losses and credits arising in tax-
8
able years beginning after December 31, 2020. 
9
TITLE IV—GROWTH IN INNOVA-
10
TION 
AND 
TECHNOLOGY 
11
BREAKTHROUGHS 
12
SEC. 401. SIMPLIFICATION AND EXPANSION OF DEDUCTION 
13
FOR START-UP AND ORGANIZATIONAL EX-
14
PENDITURES. 
15
(a) IN GENERAL.—Section 195 of the Internal Rev-
16
enue Code of 1986 is amended by redesignating sub-
17
sections (c) and (d) as subsections (d) and (e), respec-
18
tively, and by striking all that precedes subsection (d) (as 
19
so redesignated) and inserting the following: 
20
‘‘SEC. 195. START-UP AND ORGANIZATIONAL EXPENDI-
21
TURES. 
22
‘‘(a) CAPITALIZATION OF EXPENDITURES.—Except 
23
as otherwise provided in this section, no deduction shall 
24
be allowed for start-up or organizational expenditures. 
25
23:08 Oct 10, 2020
H11
41 
•HR 11 IH
‘‘(b) ELECTION TO DEDUCT.— 
1
‘‘(1) IN GENERAL.—If a taxpayer elects the ap-
2
plication of this subsection with respect to any active 
3
trade or business— 
4
‘‘(A) the taxpayer shall be allowed a deduc-
5
tion for the taxable year in which such active 
6
trade or business begins in an amount equal to 
7
the lesser of— 
8
‘‘(i) the aggregate amount of start-up 
9
and organizational expenditures paid or in-
10
curred in connection with such active trade 
11
or business, or 
12
‘‘(ii) $20,000, reduced (but not below 
13
zero) by the amount by which such aggre-
14
gate amount exceeds $120,000, and 
15
‘‘(B) the remainder of such start-up and 
16
organizational expenditures shall be charged to 
17
capital account and allowed as an amortization 
18
deduction determined by amortizing such ex-
19
penditures ratably over the 180-month period 
20
beginning with the month in which the active 
21
trade or business begins. 
22
‘‘(2) APPLICATION
TO
ORGANIZATIONAL
EX-
23
PENDITURES.—In the case of organizational expend-
24
itures with respect to any corporation or partner-
25
23:08 Oct 10, 2020
H11
42 
•HR 11 IH
ship, the active trade or business referred to in para-
1
graph (1) means the first active trade or business 
2
carried on by such corporation or partnership. 
3
‘‘(3) INFLATION ADJUSTMENT.—In the case of 
4
any taxable year beginning after December 31, 
5
2020, the $20,000 and $120,000 amounts in para-
6
graph (1)(A)(ii) shall each be increased by an 
7
amount equal to— 
8
‘‘(A) such dollar amount, multiplied by 
9
‘‘(B) the cost-of-living adjustment deter-
10
mined under section 1(f)(3) for the calendar 
11
year in which the taxable year begins, deter-
12
mined by substituting ‘calendar year 2019’ for 
13
‘calendar year 2016’ in subparagraph (A)(ii) 
14
thereof. 
15
If any amount as increased under the preceding sen-
16
tence is not a multiple of $1,000, such amount shall 
17
be rounded to the nearest multiple of $1,000. 
18
‘‘(c) ALLOWANCE OF DEDUCTION UPON LIQUIDA-
19
TION OR DISPOSITION.— 
20
‘‘(1) LIQUIDATION OF PARTNERSHIP OR COR-
21
22
completely liquidated by the taxpayer, any start-up 
23
or organizational expenditures paid or incurred in 
24
connection with such partnership or corporation 
25
23:08 Oct 10, 2020
H11
43 
•HR 11 IH
which were not allowed as a deduction by reason of 
1
this section may be deducted to the extent allowable 
2
under section 165. 
3
‘‘(2) DISPOSITION OF TRADE OR BUSINESS.—If 
4
any trade or business is completely disposed of or 
5
discontinued by the taxpayer, any start-up expendi-
6
tures paid or incurred in connection with such trade 
7
or business which were not allowed as a deduction 
8
by reason of this section (and not taken into account 
9
in connection with a liquidation to which paragraph 
10
(1) applies) may be deducted to the extent allowable 
11
under section 165. For purposes of this paragraph, 
12
in the case of any deduction allowed under sub-
13
section (b)(1) with respect to both start-up and or-
14
ganizational expenditures, the amount treated as so 
15
allowed with respect to start-up expenditures shall 
16
bear the same ratio to such deduction as the start- 
17
up expenditures taken into account in determining 
18
such deduction bears to the aggregate of the start- 
19
up and organizational expenditures so taken into ac-
20
count.’’. 
21
(b) 
ORGANIZATIONAL
EXPENDITURES.—Section 
22
195(d) of such Code, as redesignated by subsection (a), 
23
is amended by adding at the end the following new para-
24
graphs: 
25
23:08 Oct 10, 2020
H11
44 
•HR 11 IH
‘‘(3) ORGANIZATIONAL
EXPENDITURES.—The 
1
term ‘organizational expenditures’ means any ex-
2
penditure which— 
3
‘‘(A) is incident to the creation of a cor-
4
poration or a partnership, 
5
‘‘(B) is chargeable to capital account, and 
6
‘‘(C) is of a character which, if expended 
7
incident to the creation of a corporation or a 
8
partnership having an ascertainable life, would 
9
be amortizable over such life. 
10
‘‘(4) APPLICATION TO CERTAIN DISREGARDED 
11
ENTITIES.—In the case of any entity with a single 
12
owner that is disregarded as an entity separate from 
13
its owner, this section shall be applied in the same 
14
manner as if such entity were a corporation.’’. 
15
(c) ELECTION.—Section 195(e)(2) of such Code, as 
16
redesignated by subsection (a), is amended to read as fol-
17
lows: 
18
‘‘(2) PARTNERSHIPS AND S CORPORATIONS.—In 
19
the case of any partnership or S corporation, the 
20
election under subsection (b) shall be made (and this 
21
section shall be applied) at the entity level.’’. 
22
(d) CONFORMING AMENDMENTS.— 
23
(1)(A) Part VIII of subchapter B of chapter 1 
24
is amended by striking section 248 of such Code 
25
23:08 Oct 10, 2020
H11
45 
•HR 11 IH
(and by striking the item relating to such section in 
1
the table of sections of such part). 
2
(B) Section 170(b)(2)(D)(ii) of such Code is 
3
amended by striking ‘‘(except section 248)’’. 
4
(C) Section 312(n)(3) of such Code is amended 
5
by striking ‘‘Sections 173 and 248’’ and inserting 
6
‘‘Sections 173 and 195’’. 
7
(D) Section 535(b)(3) of such Code is amended 
8
by striking ‘‘(except section 248)’’. 
9
(E) Section 545(b)(3) of such Code is amended 
10
by striking ‘‘(except section 248)’’. 
11
(F) Section 545(b)(4) of such Code is amended 
12
by striking ‘‘(except section 248)’’. 
13
(G) Section 834(c)(7) of such Code is amended 
14
by striking ‘‘(except section 248)’’. 
15
(H) Section 852(b)(2)(C) of such Code is 
16
amended by striking ‘‘(except section 248)’’. 
17
(I) Section 857(b)(2)(A) of such Code is 
18
amended by striking ‘‘(except section 248)’’. 
19
(J) Section 1363(b) of such Code is amended 
20
by adding ‘‘and’’ at the end of paragraph (2), by 
21
striking paragraph (3), and by redesignating para-
22
graph (4) as paragraph (3). 
23
(K) Section 1375(b)(1)(B)(i) of such Code is 
24
amended by striking ‘‘(other than the deduction al-
25
23:08 Oct 10, 2020
H11
46 
•HR 11 IH
lowed by section 248, relating to organization ex-
1
penditures)’’. 
2
(2)(A) Section 709 of such Code is amended to 
3
read as follows: 
4
‘‘SEC. 709. TREATMENT OF SYNDICATION FEES. 
5
‘‘No deduction shall be allowed under this chapter to 
6
a partnership or to any partner of the partnership for any 
7
amounts paid or incurred to promote the sale of (or to 
8
sell) an interest in the partnership.’’. 
9
(B) The item relating to section 709 in the 
10
table of sections for part I of subchapter K of chap-
11
ter 1 of such Code is amended to read as follows: 
12
‘‘Sec. 709. Treatment of syndication fees.’’. 
(3) Section 1202(e)(2)(A) of such Code is 
13
amended by striking ‘‘section 195(c)(1)(A)’’ and in-
14
serting ‘‘section 195(d)(1)(A)’’. 
15
(4) The item relating to section 195 in the table 
16
of contents of part VI of subchapter B of chapter 1 
17
of such Code is amended to read as follows: 
18
‘‘Sec. 195. Start-up and organizational expenditures.’’. 
(e) EFFECTIVE DATE.—The amendments made by 
19
this section shall apply to expenditures paid or incurred 
20
in connection with active trades or businesses which begin 
21
in taxable years beginning after December 31, 2019. 
22
23:08 Oct 10, 2020
H11
47 
•HR 11 IH
SEC. 402. PRESERVATION OF START-UP NET OPERATING 
1
LOSSES AND TAX CREDITS AFTER OWNER-
2
SHIP CHANGE. 
3
(a) APPLICATION TO NET OPERATING LOSSES.— 
4
Section 382(d) of the Internal Revenue Code of 1986 is 
5
amended by adding at the end the following new para-
6
graph: 
7
‘‘(4) EXCEPTION FOR START-UP LOSSES.— 
8
‘‘(A) IN GENERAL.—In the case of any net 
9
operating loss carryforward described in para-
10
graph (1)(A) which arose in a start-up period 
11
taxable year, the amount of such net operating 
12
loss carryforward otherwise taken into account 
13
under such paragraph shall be reduced by the 
14
net start-up loss determined with respect to the 
15
trade or business referred to in subparagraph 
16
(B)(i) for such start-up period taxable year. 
17
‘‘(B) START-UP PERIOD TAXABLE YEAR.— 
18
The term ‘start-up period taxable year’ means 
19
any taxable year of the old loss corporation 
20
which— 
21
‘‘(i) begins before the close of the 3- 
22
year period beginning on the date on which 
23
any trade or business of such corporation 
24
begins as an active trade or business (as 
25
determined under section 195(d)(2) with-
26
23:08 Oct 10, 2020
H11
48 
•HR 11 IH
out regard to subparagraph (B) thereof), 
1
and 
2
‘‘(ii) ends after May 31, 2020. 
3
‘‘(C) NET START-UP LOSS.— 
4
‘‘(i) IN
GENERAL.—The term ‘net 
5
start-up loss’ means, with respect to any 
6
trade or business referred to in subpara-
7
graph (B)(i) for any start-up period tax-
8
able year, the amount which bears the 
9
same ratio (but not greater than 1) to the 
10
net operating loss carryforward which 
11
arose in such start-up period taxable year 
12
as— 
13
‘‘(I) the net operating loss (if 
14
any) which would have been deter-
15
mined for such start-up period taxable 
16
year if only items of income, gain, de-
17
duction, and loss properly allocable to 
18
such trade or business were taken into 
19
account, bears to 
20
‘‘(II) the amount of the net oper-
21
ating loss determined for such start- 
22
up period taxable year. 
23
‘‘(ii) SPECIAL RULE FOR LAST TAX-
24
ABLE YEAR IN START-UP PERIOD.—In the 
25
23:08 Oct 10, 2020
H11
49 
•HR 11 IH
case of any start-up period taxable year 
1
which ends after the close of the 3-year pe-
2
riod described in subparagraph (B)(i) with 
3
respect to any trade or business, the net 
4
start-up loss with respect to such trade or 
5
business for such start-up period taxable 
6
year shall be the same proportion of such 
7
loss (determined without regard to this 
8
clause) as the proportion of such start-up 
9
period taxable year which is on or before 
10
the last day of such period. 
11
‘‘(D) APPLICATION
TO
NET
OPERATING 
12
LOSS
ARISING
IN
YEAR
OF
OWNERSHIP 
13
CHANGE.—Subparagraph (A) shall apply to any 
14
net operating loss described in paragraph 
15
(1)(B) in the same manner as such subpara-
16
graph 
applies 
to 
net 
operating 
loss 
17
carryforwards described in paragraph (1)(A), 
18
but by only taking into account the amount of 
19
such net operating loss (and the amount of the 
20
net start-up loss) which is allocable under para-
21
graph (1)(B) to the period described in such 
22
paragraph. Proper adjustment in the allocation 
23
of the net start-up loss under the preceding 
24
23:08 Oct 10, 2020
H11
50 
•HR 11 IH
sentence shall be made in the case of a taxable 
1
year to which subparagraph (C)(ii) applies. 
2
‘‘(E) APPLICATION
TO
TAXABLE
YEARS 
3
WHICH ARE START-UP PERIOD TAXABLE YEARS 
4
WITH RESPECT TO MORE THAN 1 TRADE OR 
5
BUSINESS.—In the case of any net operating 
6
loss carryforward which arose in a taxable year 
7
which is a start-up period taxable year with re-
8
spect to more than 1 trade or business— 
9
‘‘(i) this paragraph shall be applied 
10
separately with respect to each such trade 
11
or business, and 
12
‘‘(ii) the aggregate reductions under 
13
subparagraph (A) shall not exceed such net 
14
operating loss carryforward. 
15
‘‘(F) CONTINUITY OF BUSINESS REQUIRE-
16
MENT.—If the new loss corporation does not 
17
continue the trade or business referred to in 
18
subparagraph (B)(i) at all times during the 2- 
19
year period beginning on the change date, this 
20
paragraph shall not apply with respect to such 
21
trade or business. 
22
‘‘(G) CERTAIN
TITLE
11
OR
SIMILAR 
23
CASES.— 
24
23:08 Oct 10, 2020
H11
51 
•HR 11 IH
‘‘(i) 
MULTIPLE
OWNERSHIP 
1
CHANGES.—In the case of a 2nd ownership 
2
change to which subsection (l)(5)(D) ap-
3
plies, this paragraph shall not apply for 
4
purposes of determining the pre-change 
5
loss with respect to such 2nd ownership 
6
change. 
7
‘‘(ii) CERTAIN
INSOLVENCY
TRANS-
8
ACTIONS.—If subsection (l)(6) applies for 
9
purposes of determining the value of the 
10
old loss corporation under subsection (e), 
11
this paragraph shall not apply. 
12
‘‘(H) NOT
APPLICABLE
TO
DISALLOWED 
13
INTEREST.—This paragraph shall not apply for 
14
purposes of applying the rules of paragraph (1) 
15
to the carryover of disallowed interest under 
16
paragraph (3). 
17
‘‘(I) TRANSITION RULE.—This paragraph 
18
shall not apply with respect to any trade or 
19
business if the date on which such trade or 
20
business begins as an active trade or business 
21
(as determined under section 195(d)(2) without 
22
regard to subparagraph (B) thereof) is on or 
23
before May 31, 2020.’’. 
24
23:08 Oct 10, 2020
H11
52 
•HR 11 IH
(b) APPLICATION TO EXCESS CREDITS.—Section 383 
1
of such Code is amended by redesignating subsection (e) 
2
as subsection (f) and by inserting after subsection (d) the 
3
following new subsection: 
4
‘‘(e) EXCEPTION FOR START-UP EXCESS CREDITS.— 
5
‘‘(1) IN GENERAL.—In the case of any unused 
6
general business credit of the corporation under sec-
7
tion 39 which arose in a start-up period taxable 
8
year, the amount of such unused general business 
9
credit otherwise taken into account under subsection 
10
(a)(2)(A) shall be reduced by the start-up excess 
11
credit determined with respect to any trade or busi-
12
ness referred to in section 382(d)(4)(B)(i) for such 
13
start-up period taxable year. 
14
‘‘(2) START-UP PERIOD TAXABLE YEAR.—For 
15
purposes of this subsection, the term ‘start-up pe-
16
riod taxable year’ has the meaning given such term 
17
in section 382(d)(4)(B). 
18
‘‘(3) START-UP EXCESS CREDIT.—For purposes 
19
of this subsection, the term ‘start-up excess credit’ 
20
means, with respect to any trade or business re-
21
ferred to in section 382(d)(4)(B)(i) for any start-up 
22
period taxable year, the amount which bears the 
23
same ratio to the unused general business credit 
24
23:08 Oct 10, 2020
H11
53 
•HR 11 IH
which arose in such start-up period taxable year 
1
as— 
2
‘‘(A) the amount of the general business 
3
credit which would have been determined for 
4
such start-up period taxable year if only credits 
5
properly allocable to such trade or business 
6
were taken into account, bears to 
7
‘‘(B) the amount of the general business 
8
credit determined for such start-up period tax-
9
able year. 
10
‘‘(4) APPLICATION OF CERTAIN RULES.—Rules 
11
similar to the rules of subparagraphs (C)(ii), (D), 
12
(E), and (F) of section 382(d)(4) shall apply for 
13
purposes of this subsection. 
14
‘‘(5) TRANSITION RULE.—This subsection shall 
15
not apply with respect to any trade or business if 
16
the date on which such trade or business begins as 
17
an active trade or business (as determined under 
18
section 195(d)(2) without regard to subparagraph 
19
(B) thereof) is on or before May 31, 2020.’’. 
20
(c) EFFECTIVE DATE.—The amendments made by 
21
this section shall apply to taxable years ending after May 
22
31, 2020. 
23
Æ 
23:08 Oct 10, 2020
H11
